Auerbach, LLC was founded in 2011 by Jeffrey I. Auerbach, Ph.D., an attorney with more than 35 years of experience in intellectual property and technology law. The firm was located near Washington, DC, in Rockville, Maryland. In 2024, Dr. Auerbach retired from the practice of law and the firm ceased its operations. We are grateful to our many clients for their support over a career of nearly 40 years.
Auerbach, LLC focused on providing US and foreign businesses and institutions with counseling and services in the areas of patent rights and technology licensing. The firm used a strategic and targeted approach to develop coordinated, global intellectual property protection programs that were tailored to the specific goals and resources of its clients. It coordinated with foreign counsel throughout the world to implement such programs, and managed the complex worldwide dockets of its clients’ patent portfolios. Auerbach, LLC developed long term relationships with its clients by providing them with high quality work and consistent value. The firm had substantial expertise in all areas of technology, with particular fluency in biotechnology.
Dr. Auerbach received his B.S. degree in biochemistry, genetics, and microbiology from Cornell University in 1975. He received his M.Phil. (1977) and Ph.D. (1981) degrees in molecular biophysics and biochemistry from Yale University. Before entering into a career in patent law, Dr. Auerbach served as a research scientist at the Laboratory of Molecular Biology of the National Cancer Institute, at W.R. Grace & Company, and at SmithKline & French Laboratories (where he received that company’s highest research award). Dr. Auerbach began his career in patent law in 1985 and received his J.D. degree in 1989, from George Washington University. Prior to forming Auerbach, LLC, Dr. Auerbach was an associate at Weil, Gotshal & Manges, and a partner at Howrey, LLP.​
Although his practice primarily focused on biotechnology law, Dr. Auerbach’s background in biophysics permitted him to work in a broad array of other technologies, including computer architecture, material sciences, polymer chemistry, software and telecommunication protocols. Dr. Auerbach’s clients included Genentech, Inc., H. Lundbeck A/S, DiaSorin S.p.A., The Monsanto Company, Boehringer Ingelheim GmbH, Baidu, Inc., MacroGenics, Inc., the US National Institutes of Health, the University of Maryland, New York University, Yale University, Princeton University, the University of Oxford, Hiroshima University and the University of Tokyo. Dr. Auerbach has served as counsel in some of the most complex biotechnology licensing, trade secret and patent disputes to have arisen in the past 40 years.
Dr. Auerbach is also an inventor, having received patents in the United States and throughout the world for his inventions in vaccine production, and isothermal “rolling circle” nucleic acid amplification. In 1994, he founded Replicon, Inc., a Maryland biotechnology company focused on the use of rolling circle amplification in diagnostics, genomics and therapeutics, and served as its president until its 2003 acquisition by Biokit S.A. Dr. Auerbach is a philanthropist and has served as a member and Diplomat of the Washington, DC Board of the American Committee for the Weizmann Institute of Science, and and as a Director of the International Biomedical Research Alliance.
Dr. Auerbach is a member of the bars of Maryland, Virginia, New York and the District of Columbia, and is registered to practice before the U.S. Patent and Trademark Office. Dr. Auerbach has served as an adjunct faculty member of the Johns Hopkins University, teaching courses in biotechnology law, and is the author of many publications, including the web monograph “Patent Law Principles and Strategies.” Dr. Auerbach’s biography has appeared in “Marquis® Who’s Who in American Law” and “Marquis® Who’s Who in America.” He is nationally peer-rated by Martindale-Hubbell / Reed Elsevier Properties, Inc.
